Financials
- Market Capitalization 12.47 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-45.32
Fiyat/satışlar oranı
13.63
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 703 | BBIO BridgeBio Pharma, Inc. - Common Stock | 77.02 USD | -2.11% | -5.97% | -8.98% | +35.12% | 15.06 B USD | ||
| 766 | EXEL Exelixis, Inc. - Common Stock | 54.17 USD | -1.97% | -0.44% | -4.04% | +38.76% | 13.42 B USD | ||
| 802 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 64.64 USD | -1.00% | -3.09% | +4.14% | +12.34% | 12.51 B USD | ||
| 811 | CORT Corcept Therapeutics Incorporated - Common Stock | 113.71 USD | -2.75% | -6.42% | +19.69% | +54.98% | 12.29 B USD |